28105138|t|Clinical and angiographic correlation of high-sensitivity C-reactive protein with acute ST elevation myocardial infarction
28105138|a|Vascular inflammation and associated ongoing inflammatory responses are considered as the critical culprits in the pathogenesis of acute atherothrombotic events such as acute coronary syndrome (ACS) and myocardial infarction (MI). ST segment elevation myocardial infarction (STEMI) is considered as one of the prominent clinical forms of ACS. Moreover, C-reactive protein (CRP) is an important acute phase prsotein, which may be estimated using high-sensitivity methods (hs-CRP), and its elevated level in body fluids reflects chronic inflammatory status. The circulating hs-CRP level has been proposed as a promising inflammatory marker of coronary artery disease (CAD). The present study investigated the correlation of hs-CRP level with clinical and angiographic features of STEMI, various other traditional risk factors, complications of myocardial infarction and angiographically significant CAD. Out of 190 patients with STEMI that were analyzed, the interval between symptom onset and reperfusion therapy (window period) varied from 0.5 to 24 h. The hs-CRP value was found to be higher in non-diabetic patients (0.61 mg/dl) compared with diabetic patients (0.87 mg/dl). Moreover, a significant correlation between hs-CRP and hs-troponin T was also recorded (P<0.001). However, there was no significant difference in the mean hs-CRP values in patients with or without mortality. It is considered that the present study will increase the understanding of atherosclerosis in general and may also have clinical applications in the targeting of therapy for this harmful disease.
28105138	0	8	Clinical	T080	C0205210
28105138	13	25	angiographic	T060	C0002978
28105138	26	37	correlation	T080	C1707520
28105138	41	76	high-sensitivity C-reactive protein	T116,T129	C0006560
28105138	82	122	acute ST elevation myocardial infarction	T047	C1303258
28105138	123	144	Vascular inflammation	T047	C0947751
28105138	168	190	inflammatory responses	T046	C1155266
28105138	238	250	pathogenesis	T046	C0699748
28105138	254	259	acute	T079	C0205178
28105138	260	276	atherothrombotic	T020	C1963943
28105138	277	283	events	T051	C0441471
28105138	292	315	acute coronary syndrome	T047	C0948089
28105138	317	320	ACS	T047	C0948089
28105138	326	347	myocardial infarction	T047	C0027051
28105138	349	351	MI	T047	C0027051
28105138	354	396	ST segment elevation myocardial infarction	T047	C1536220
28105138	398	403	STEMI	T047	C1536220
28105138	443	451	clinical	T080	C0205210
28105138	452	457	forms	T080	C0348078
28105138	461	464	ACS	T047	C0948089
28105138	476	494	C-reactive protein	T116,T129	C0006560
28105138	496	499	CRP	T116,T129	C0006560
28105138	517	537	acute phase prsotein	T116,T123	C0001347
28105138	568	592	high-sensitivity methods	T059	C3839560
28105138	594	600	hs-CRP	T059	C3839560
28105138	611	619	elevated	T080	C3163633
28105138	620	625	level	T034	C0428528
28105138	629	640	body fluids	T031	C0005889
28105138	650	670	chronic inflammatory	T046	C0021376
28105138	671	677	status	T080	C0449438
28105138	695	701	hs-CRP	T059	C3839560
28105138	702	707	level	T034	C0428528
28105138	741	753	inflammatory	T046	C0021368
28105138	754	760	marker	T201	C0005516
28105138	764	787	coronary artery disease	T047	C0010054
28105138	789	792	CAD	T047	C0010054
28105138	807	812	study	T062	C2603343
28105138	813	825	investigated	T169	C1292732
28105138	830	841	correlation	T080	C1707520
28105138	845	851	hs-CRP	T059	C3839560
28105138	852	857	level	T034	C0428528
28105138	863	871	clinical	T080	C0205210
28105138	876	888	angiographic	T060	C0002978
28105138	889	897	features	T080	C2348519
28105138	901	906	STEMI	T047	C1536220
28105138	934	946	risk factors	T033	C0035648
28105138	948	961	complications	T046	C0009566
28105138	965	986	myocardial infarction	T047	C0027051
28105138	991	1019	angiographically significant	T078	C0750502
28105138	1020	1023	CAD	T047	C0010054
28105138	1036	1044	patients	T101	C0030705
28105138	1050	1055	STEMI	T047	C1536220
28105138	1066	1074	analyzed	T062	C0936012
28105138	1080	1088	interval	T079	C1272706
28105138	1097	1110	symptom onset	T079	C4086878
28105138	1115	1134	reperfusion therapy	T061	C0035124
28105138	1136	1149	window period	T079	C1948053
28105138	1173	1174	h	T079	C0439227
28105138	1180	1186	hs-CRP	T059	C3839560
28105138	1219	1240	non-diabetic patients	T101	C0030705
28105138	1254	1262	compared	T052	C1707455
28105138	1268	1276	diabetic	T047	C0011847
28105138	1277	1285	patients	T101	C0030705
28105138	1324	1335	correlation	T080	C1707520
28105138	1344	1350	hs-CRP	T059	C3839560
28105138	1355	1368	hs-troponin T	T059	C3827339
28105138	1455	1461	hs-CRP	T059	C3839560
28105138	1462	1468	values	T080	C0042295
28105138	1472	1480	patients	T101	C0030705
28105138	1497	1506	mortality	T081	C0205848
28105138	1542	1547	study	T062	C2603343
28105138	1583	1598	atherosclerosis	T047	C0004153
28105138	1628	1649	clinical applications	T058	C1254363
28105138	1670	1677	therapy	T061	C0087111
28105138	1695	1702	disease	T047	C0012634